Tumor intrinsic pathways including STK11/LKB1 and KEAP1 are associated with non-T cell-inflamed tumor microenvironment (TME), which is also called a “cold” tumor, thus impairing the clinical efficacy of immunotherapy (50). This evidence concerns the gene KEAP1 and neoplasm.